Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. | Cells | 2022 | 36497191 | PubTator, text mining | PubMed |
| SARS-CoV-2-Associated ssRNAs Activate Human Neutrophils in a TLR8-Dependent Fashion. | Cells | 2022 | 36497044 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Reveals the Regulatory Role of Maresin1 on Neutrophils during Septic Lung Injury. | Cells | 2022 | 36496993 | PubTator, text mining | PubMed |
| CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma. | J Int Med Res | 2022 | 36495170 | PubTator, text mining | PubMed |
| Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. | Cell | 2022 | 36493752 | PubTator, text mining | PubMed |
| A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes. | Nat Commun | 2022 | 36473860 | PubTator, text mining | PubMed |
A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma. | Front Immunol | 2022 | 36458010 | PubTator, text mining | PubMed |
| Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs. | Nat Immunol | 2022 | 36456734 | PubTator, text mining | PubMed |
| The immunological function of CXCR2 in the liver during sepsis. | J Inflamm (Lond) | 2022 | 36451225 | PubTator, text mining | PubMed |
| Precision Exercise Medicine: Sex Specific Differences in Immune and CNS Responses to Physical Activity. | Brain Plast | 2022 | 36448044 | PubTator, text mining | PubMed |
| Four emerging immune cellular blood phenotypes associated with disease duration and activity established in Psoriatic Arthritis. | Arthritis Res Ther | 2022 | 36447253 | PubTator, text mining | PubMed |
| Frequency and functional profile of circulating TCRαβ+ double negative T cells in HIV/TB co-infection. | BMC Infect Dis | 2022 | 36443691 | PubTator, text mining | PubMed |
| Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. | Theranostics | 2022 | 36438481 | PubTator, text mining | PubMed |
| ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression. | Nat Commun | 2022 | 36435834 | PubTator, text mining | PubMed |
| Mobilization of Hematopoietic Stem and Progenitor Cells during Dengue Virus Infection. | Int J Mol Sci | 2022 | 36430807 | PubTator, text mining | PubMed |
| Comprehensive Assessment of Secreted Immuno-Modulatory Cytokines by Serum-Differentiated and Stem-like Glioblastoma Cells Reveals Distinct Differences between Glioblastoma Phenotypes. | Int J Mol Sci | 2022 | 36430641 | PubTator, text mining | PubMed |
| Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer. | Ther Adv Med Oncol | 2022 | 36425871 | PubTator, text mining | PubMed |
| Radiation Type- and Dose-Specific Transcriptional Responses across Healthy and Diseased Mammalian Tissues. | Antioxidants (Basel) | 2022 | 36421472 | PubTator, text mining | PubMed |
| MSCs vs. iPSCs: Potential in therapeutic applications. | Front Cell Dev Biol | 2022 | 36407112 | PubTator, text mining | PubMed |
| Glis1 and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival. | Front Mol Biosci | 2022 | 36406265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=41